The IV formulation of fosfomycin was found to be effective in treating complicated UTIs, including acute pyelonephritis, compared with IV piperacillin-tazobactam, according to research published in Clinical Infectious Diseases
“Fosfomycin has a broad spectrum of activity, and often retains activity against multidrug-resistant gram-negative and gram-positive bacteria,” Infectious Disease News Editorial Board Member Keith S. Kaye, MD, MPH, director of clinical research in the division of infectious disease at the University of Michigan, told Infectious Disease News. “Although

Source link